ArticleMolecular oncology2020

The BCL-2 family protein inhibitor ABT-737 as an additional tool for the treatment of EBV-associated post-transplant lymphoproliferative disorders.

Aude Robert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.